ZyVersa Therapeutics, Inc. Profile Avatar - Palmy Investing

ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segm…

Biotechnology
US, Weston [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of ZVSA's Analysis
CIK: - CUSIP: - ISIN: US98987D2018 LEI: - UEI: -
Secondary Listings
ZVSA has no secondary listings inside our databases.